-
Abbott
Gov. Greg Abbott announced Dec. 14 that FUJI FILM Diosynth Biotechnologies will expand their campus in College Station-Bryan with an additional commercial manufacturing facility.
FUJIFILM Diosynth Biotechnologies, a partnership between FUJIFILM Corporation and Mitsubishi Corporation, is a world-leading Contract Development and Manufacturing Organization (CDMO) with experience in the development and manufacture of recombinant bio pharmaceuticals and viral gene therapies. The project is expected to create approximately 150 new jobs and approximately $300 million in capital investment from FUJI FILM Corporation. A Texas Enterprise Fund (TEF) grant of $1,500,000 has been extended to FUJIFILM Diosynth Biotechnologies.
“FUJIFILM Diosynth Biotechnologies’ expansion is wonderful news for the hardworking people of College Station-Bryan, and it will bring more opportunities for Texans to develop life-saving technology and treatment,” said Abbott. “The biotechnology industry is growing at a tremendous rate in Texas, and I thank FUJIFILM Diosynth Biotechnologies for their continued investment in the Brazos Valley that will keep the Lone Star State competitive in this field.”
“The biopharmaceutical industry’s need for manufacturing capacity continues to grow rapidly,” said Gerry Farrell, chief operating officer for FUJIFILM Diosynth Biotechnologies Texas. “Committed to being a partner for life for our customers, we will continue to invest in the right technology and talent to support our partners in bringing to market these life-impacting medicines. We are grateful to Governor Greg Abbott, and the State of Texas for its commitment to supporting the growth of the Texas biocorridor, and creating highly-skilled jobs in the state.”
